Adicet Bio Inc [NASDAQ: ACET] traded at a low on 2025-10-07, posting a -14.69 loss after which it closed the day’ session at $0.85.
The results of the trading session contributed to over 25848502 shares changing hands. Over the past one week, the price volatility of Adicet Bio Inc stands at 12.04% while the volatility over the past one month is 8.50%.
The market cap for ACET stock reached $71.02 million, with 83.25 million shares outstanding and 65.71 million shares in the current float. Compared to the average trading volume of 502.46K shares, ACET reached a trading volume of 25848502 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adicet Bio Inc [ACET]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACET shares is $6.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACET stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Adicet Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 30, 2024. The new note on the price target was released on September 11, 2024, representing the official price target for Adicet Bio Inc stock.
The Price to Book ratio for the last quarter was 0.53, with the Price to Cash per share for the same quarter was set at 1.50.
How has ACET stock performed recently?
Adicet Bio Inc [ACET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.29. With this latest performance, ACET shares gained by 11.84% in over the last four-week period, additionally plugging by 37.57% over the last 6 months – not to mention a drop of -11.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACET stock in for the last two-week period is set at 53.82, with the RSI for the last a single of trading hit 0.0790, and the three-weeks RSI is set at 0.0652 for Adicet Bio Inc [ACET]. The present Moving Average for the last 50 days of trading for this stock 0.7525, while it was recorded at 0.8675 for the last single week of trading, and 0.7709 for the last 200 days.
Adicet Bio Inc (ACET) Capital Structure & Debt Analysis
According to recent financial data for Adicet Bio Inc. ( ACET), the Return on Equity (ROE) stands at -64.39%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -54.95%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Adicet Bio Inc’s Return on Invested Capital (ROIC) is -81.38%, showcasing its effectiveness in deploying capital for earnings.
Adicet Bio Inc (ACET) Efficiency & Liquidity Metrics
Based on Adicet Bio Inc’s (ACET) latest financial statements, the Debt-to-Equity Ratio is 0.12%, indicating its reliance on debt financing relative to shareholder equity.
Adicet Bio Inc (ACET) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Adicet Bio Inc. (ACET) effectively leverages its workforce, generating an average of -$780526.32 per employee. The company’s liquidity position is robust, with a Current Ratio of 7.48% and a Quick Ratio of 7.48%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Adicet Bio Inc [ACET]
With the latest financial reports released by the company, Adicet Bio Inc posted -0.34/share EPS, while the average EPS was predicted by analysts to be reported at -0.33/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adicet Bio Inc go to 17.63%.
Insider trade positions for Adicet Bio Inc [ACET]
There are presently around $60.91%, or 62.63%% of ACET stock, in the hands of institutional investors. The top three institutional holders of ACET stocks are: ORBIMED ADVISORS LLC with ownership of 11.45 million shares, which is approximately 12.6303%. TANG CAPITAL MANAGEMENT LLC, holding 8.22 million shares of the stock with an approximate value of $$9.94 million in ACET stocks shares; and TANG CAPITAL MANAGEMENT LLC, currently with $$9.12 million in ACET stock with ownership which is approximately 8.3205%.
